Manhattan Associates, Inc’s recent filing unveils that its Executive Chairman Capel Eddie unloaded Company’s shares for reported $8.3 million on Jul 29 ’25. In the deal valued at $222.18 per share,37,342 shares were sold. As a result of this transaction, Capel Eddie now holds 162,988 shares worth roughly $35.17 million.
Then, Hollembaek Linda T. sold 2,024 shares, generating $448,380 in total proceeds. Upon selling the shares at $221.53, the Director now owns 11,907 shares.
Before that, Gantt James Stewart sold 2,300 shares. Manhattan Associates, Inc shares valued at $506,759 were divested by the EVP, Professional Services at a price of $220.33 per share. As a result of the transaction, Gantt James Stewart now holds 48,660 shares, worth roughly $10.5 million.
Morgan Stanley initiated its Manhattan Associates, Inc [MANH] rating to an Underweight in a research note published on July 14, 2025; the price target was $190. A number of analysts have revised their coverage, including Redburn Atlantic’s analysts, who decreased its forecast for the stock in early June from “a Buy” to “a Neutral”. Loop Capital also remained covering MANH and has decreased its forecast on April 10, 2025 with a “Hold” recommendation from previously “Buy” rating. William Blair revised its rating on February 13, 2025. It rated MANH as “an Outperform” which previously was an “a Mkt perform”.
Price Performance Review of MANH
On Tuesday, Manhattan Associates, Inc [NASDAQ:MANH] saw its stock fall -1.27% to $215.77. Over the last five days, the stock has lost -4.28%. Manhattan Associates, Inc shares have fallen nearly -13.92% since the year began. Nevertheless, the stocks have fallen -20.16% over the past one year.
How much short interest is there in Manhattan Associates, Inc?
A steep rise in short interest was recorded in Manhattan Associates, Inc stocks on 2025-07-15, dropping by -0.14 million shares to a total of 1.87 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 2.01 million shares. There was a decline of -7.4%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on November 25, 2024 when Piper Sandler began covering the stock and recommended ‘”an Overweight”‘ rating along with a $326 price target.
